Casdin Capital, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.30B2026 Q3
Positions48
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.76.1%

Casdin Capital, LLC reported 48 positions worth $2.30B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RVMD (23.0%). Biggest move: new buy TEM ($34.7M).

10 / 48 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 RVMDRevolution Medicines$529.0M23.04%2,577,333——-18.7%
▸ 2 RLAYRelay Therapeutics$289.4M12.61%16,035,240——-4.3%
▸ 3 WGSGeneDx$268.0M11.68%3,707,164——-29.4%
▸ 4 BLFSBiolife Solutions$174.8M7.62%4,500,000——-0.6%
▸ 5 ILMNIllumina$145.1M6.32%530,000——-27.7%
▸ 6 GRALGrail$95.3M4.15%680,000——-17.3%
▸ 7 TXG10x Genomics$94.9M4.13%1,050,000——-39.1%
▸ 8 LABStandard Biotools$65.8M2.86%88,783,856——-16.1%
▸ 9 NGNENeurogene$44.1M1.92%1,585,361——-14.0%
▸ 10 SRRKScholar Rock$41.1M1.79%850,000——-7.8%

Pro Feature

The remaining 38 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Casdin Capital, LLC hold as of Q3 2026?

Casdin Capital, LLC reported 48 positions worth $2.30B in its Q3 2026 13F filing. Largest positions: RVMD (23.0%), RLAY (12.6%), WGS (11.7%), BLFS (7.6%) and ILMN (6.3%).

What did Casdin Capital, LLC buy in Q3 2026?

New positions: TEM, ORIC, BIIB, EWTX and BNTX (7 in all). Added to: GRAL, SRPT, ALNY, SRRK and BEAM (8 in all).

What did Casdin Capital, LLC sell in Q3 2026?

Reduced: DNLI, BLFS, GPCR, PSNL and GLUE. Sold out entirely: SION and IRON.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.